Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Salvatori

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Gastroenterology & Hepatology|April 27, 2021
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literatureSilvia Salvatori, Irene Marafini, Giovanni Monteleone
Journal of Clinical Medicine|February 27, 2026
Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary CareSilvia Salvatori, Irene Marafini, Giovanni Monteleone
Expert Opinion on Biological Therapy|July 24, 2025
Advanced therapies targeting IL-23: clinical outcomes in ulcerative colitisSilvia Salvatori, Irene Marafini, Antonio Fonsi, et al.
Journal of Clinical Medicine|December 10, 2021
Long COVID in Inflammatory Bowel DiseasesSilvia Salvatori, Francesco Baldassarre, Michelangela Mossa, et al.
Pharmacological Research|March 21, 2020
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseasesIrene Marafini, Edoardo Troncone, Silvia Salvatori, et al.
Biomedicines|January 28, 2026
Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized TherapyIrene Marafini, Silvia Salvatori, Antonio Fonsi, et al.
Frontiers in Immunology|November 6, 2025
Fundamental and emerging insights into innate and adaptive immunity in inflammatory bowel diseasesGiovanni Monteleone, Carlo Calisi, Silvia Salvatori, et al.
International Journal of Molecular Sciences|February 11, 2023
<i>Helicobacter pylori</i> and Gastric Cancer: Pathogenetic MechanismsSilvia Salvatori, Irene Marafini, Federica Laudisi, et al.
Cell Death Discovery|September 18, 2021
Interleukin-34 promotes tumorigenic signals for colon cancer cellsEleonora Franzè, Irene Marafini, Edoardo Troncone, et al.
Expert Opinion on Emerging Drugs|September 5, 2023
Emerging oral drug options for ulcerative colitisSilvia Salvatori, Benedetto Neri, Irene Marafini, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Gastroenterology & Hepatology|April 27, 2021
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literatureSilvia Salvatori, Irene Marafini, Giovanni Monteleone
Journal of Clinical Medicine|February 27, 2026
Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary CareSilvia Salvatori, Irene Marafini, Giovanni Monteleone
Expert Opinion on Biological Therapy|July 24, 2025
Advanced therapies targeting IL-23: clinical outcomes in ulcerative colitisSilvia Salvatori, Irene Marafini, Antonio Fonsi, et al.
Journal of Clinical Medicine|December 10, 2021
Long COVID in Inflammatory Bowel DiseasesSilvia Salvatori, Francesco Baldassarre, Michelangela Mossa, et al.
Pharmacological Research|March 21, 2020
TGF-β activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseasesIrene Marafini, Edoardo Troncone, Silvia Salvatori, et al.
Biomedicines|January 28, 2026
Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized TherapyIrene Marafini, Silvia Salvatori, Antonio Fonsi, et al.
Frontiers in Immunology|November 6, 2025
Fundamental and emerging insights into innate and adaptive immunity in inflammatory bowel diseasesGiovanni Monteleone, Carlo Calisi, Silvia Salvatori, et al.
International Journal of Molecular Sciences|February 11, 2023
<i>Helicobacter pylori</i> and Gastric Cancer: Pathogenetic MechanismsSilvia Salvatori, Irene Marafini, Federica Laudisi, et al.
Cell Death Discovery|September 18, 2021
Interleukin-34 promotes tumorigenic signals for colon cancer cellsEleonora Franzè, Irene Marafini, Edoardo Troncone, et al.
Expert Opinion on Emerging Drugs|September 5, 2023
Emerging oral drug options for ulcerative colitisSilvia Salvatori, Benedetto Neri, Irene Marafini, et al.
Pageof 4